Nov 30, 2017   SOURCE: PR NewsWire

Global Radiotherapy Market to 2023 - Rising Incidence and Prevalence of Cancer & Rising Technological Advancements

DUBLIN, November 30, 2017 /PRNewswire/ --

The "Global Radiotherapy Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023" report has been added to Research and Markets' offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The global radiotherapy device market is impeded to grow at a significant CAGR of 6.8% during the forecast period of 2016-2023

Key drivers for the global radiotherapy device market are rising incidence and prevalence of cancer, rising technological advancements such as stereotactic body radiation therapy, advancements in proton therapy, rising adoption of radiotherapy devices and procedures, growing geriatric population as persons over 65 years reported for 60% of newly diagnosed malignancies and 70% of all cancer deaths and increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy.

However, the major restraining factors of the global radiotherapy device market are lack of adequate healthcare infrastructure and lack of trained personnel. Apart from this, the major challenges present in the market are difficulties in visualizing tumors during radiation procedures and affordability and accessibility of treatment. However, to overcome these market challenges, key opportunities for the global radiotherapy device market are emerging markets and rising investments to meet the increased demand for cancer treatment.

Key market vendors for the global radiotherapy device market include Varian Medical Systems, Inc. (U.S) Mitsubishi Electric Corporation (Japan), RaySearch Laboratories (Sweden), Mevion Medical Systems. Inc (U.S), Ion Beam Applications (IBA) (Belgium). These companies are using various strategies such as merger & acquisitions, collaboration, partnership and product launch to hold large market share.

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Competitive Landscape

6. Geographical Analysis

7. Company Profiles

    --  Accuray Incorporated
    --  C.R. Bard , Inc
    --  Coviden Plc Overview
    --  Elekta Ab
    --  IBA (Ion Beam Applications Sa)
    --  Mevion Medical Systems, Inc
    --  Mitsubishi Electric Corporation
    --  Nordian, Inc
    --  Panacea Medical Technologies Pvt. Ltd
    --  P-Cure Ltd
    --  Pronova Solutions , Llc
    --  Raysearch Laboratories
    --  Theragenics Corporation
    --  Varian Medical Systems , Inc
    --  Viewray Inc.

For more information about this report visit https://www.researchandmarkets.com/research/dv2kqn/global

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-radiotherapy-market-to-2023---rising-incidence-and-prevalence-of-cancer--rising-technological-advancements-300564493.html

SOURCE Research and Markets